Invention relates to site specific formulation for effective treatment of cancer. Proliposomal formulation for effective treatment of cancer comprises therapeutically effective amount of anticancer agent, phospholipids, cholesterol and coating polymer. The anticancer agent is paclitaxel , and the phospholipids are egg phosphatidylglycerol and distearoyl phosphatidylcholine.
Technologies